WO2012120532A3 - Cyclic short chain pth analog peptides - Google Patents

Cyclic short chain pth analog peptides Download PDF

Info

Publication number
WO2012120532A3
WO2012120532A3 PCT/IN2012/000078 IN2012000078W WO2012120532A3 WO 2012120532 A3 WO2012120532 A3 WO 2012120532A3 IN 2012000078 W IN2012000078 W IN 2012000078W WO 2012120532 A3 WO2012120532 A3 WO 2012120532A3
Authority
WO
WIPO (PCT)
Prior art keywords
short chain
analog peptides
pth analog
cyclic
cyclic short
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2012/000078
Other languages
French (fr)
Other versions
WO2012120532A2 (en
Inventor
Rajesh H Bahekar
Vjay PRAJAPATI
Mukul R. Jain
Pankaj R. Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zydus Lifesciences Ltd
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of WO2012120532A2 publication Critical patent/WO2012120532A2/en
Publication of WO2012120532A3 publication Critical patent/WO2012120532A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides novel cyclic short-chain peptideshaving pharmaceutically beneficial properties. The invention also provides a process for preparing such short chain peptides and pharmaceutical compositions containing the cyclic peptides of the present invention. A-Z 1-Z2-Z3-Z4-Z5-Z6-Z7-Z8-Z9-Z10-Z11-Z 12-Z13-Z 14-Z 15-B (I)
PCT/IN2012/000078 2011-02-02 2012-02-02 Cyclic short chain peptides Ceased WO2012120532A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN301MU2011 2011-02-02
IN301/MUM/2011 2011-02-02

Publications (2)

Publication Number Publication Date
WO2012120532A2 WO2012120532A2 (en) 2012-09-13
WO2012120532A3 true WO2012120532A3 (en) 2013-03-14

Family

ID=46579272

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2012/000078 Ceased WO2012120532A2 (en) 2011-02-02 2012-02-02 Cyclic short chain peptides

Country Status (1)

Country Link
WO (1) WO2012120532A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113736741A (en) * 2021-08-18 2021-12-03 上海市食品药品检验研究院 A cloned cell line for determining the biological activity of teriparatide
CN115925802B (en) * 2023-02-22 2024-07-23 西南交通大学 Antibacterial peptide with enhanced antibacterial activity and serum stability and application thereof
WO2025250872A1 (en) * 2024-05-31 2025-12-04 Florida Atlantic University Board Of Trustees Antibody complementary determining region of heavy chain 3 mimics and methods of use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067021A1 (en) * 2003-01-24 2004-08-12 Gardella Thomas J Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
WO2008068487A1 (en) * 2006-12-08 2008-06-12 Zealand Pharma A/S Truncated pth peptides with a cyclic conformation
WO2010128521A2 (en) * 2009-04-24 2010-11-11 Cadila Healthcare Limited Short-chain peptides as parathyroid hormone (pth) receptor agonist

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1447600A (en) 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
CA2454275C (en) 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
AU2002951372A0 (en) 2002-09-13 2002-09-26 St Vincent's Institute Of Medical Research Parathyroid hormone-like polypeptides
US7795220B2 (en) 2003-03-19 2010-09-14 The General Hospital Corporation Conformationally constrained parathyroid hormones with alpha-helix stabilizers
WO2005009358A2 (en) 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
WO2005077918A1 (en) 2004-02-11 2005-08-25 Smithkline Beecham Corporation Pth agonists
WO2005077959A1 (en) 2004-02-11 2005-08-25 Smithkline Beecham Corporation Pth agonists
ITMI20041440A1 (en) 2004-07-19 2004-10-19 Abiogen Pharma Spa ANALOGUE PEPTIDES OF PTH-1-11
WO2007130113A2 (en) 2005-09-06 2007-11-15 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067021A1 (en) * 2003-01-24 2004-08-12 Gardella Thomas J Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
WO2008068487A1 (en) * 2006-12-08 2008-06-12 Zealand Pharma A/S Truncated pth peptides with a cyclic conformation
WO2010128521A2 (en) * 2009-04-24 2010-11-11 Cadila Healthcare Limited Short-chain peptides as parathyroid hormone (pth) receptor agonist

Also Published As

Publication number Publication date
WO2012120532A2 (en) 2012-09-13

Similar Documents

Publication Publication Date Title
WO2011086093A3 (en) Pharmaceutical compositions for oral administration of insulin peptides
MY161773A (en) Amylin analogues and pharmaceutical compositions thereof
WO2011138281A3 (en) Process for the preparation of dithiine tetracarboxydiimides
MX339533B (en) Dac hyp compositions and methods.
PH12014501162A1 (en) Aryl dihydropyridinone and piperidinone as mgat2 inhibitors
WO2011157721A3 (en) Ivabradine-containing pharmaceutical composition
WO2010092090A3 (en) Novel salts of sitagliptin
WO2012047656A8 (en) Lipid a analog compositions
ZA201301463B (en) Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same
IL222999A (en) Process for the preparation of pleuromutilins, intermediates and pharmaceutical compositions comprising pleuromutilin compounds
WO2013055684A8 (en) Rasagiline citramide
WO2013080217A3 (en) Crystalline forms of carbazitaxel and process for preparation thereof
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
WO2012070062A3 (en) Novel polymorph of nilotinib hydrochloride
WO2013093931A3 (en) Novel prodrugs of phenolic drugs
WO2012131707A3 (en) Crystalline form of bortezomib, preparation method and pharmaceutical composition there f
WO2013074871A3 (en) Humanin analogs
WO2012120532A3 (en) Cyclic short chain pth analog peptides
PH12013500210A1 (en) Highly crystalline valsartan
WO2013150550A3 (en) An improved process for the preparation of carbapenem antibiotic
MX343701B (en) Process for alkynylating 16-substituted-17-keto steroids.
MX2013012773A (en) Drug substances, pharmeceutical compositions and methods for preparing the same.
AU2009235968A8 (en) Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
WO2012168680A8 (en) Pharmaceutical preparation comprising recombinant fsh
MY181682A (en) Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12738621

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12738621

Country of ref document: EP

Kind code of ref document: A2